Thursday , August 11 2022

Novavida supports the research of immune cancer.



[ad_1]

Bangkok – November 12 – Nova Vida

The Integrative Medical Center of Novavida donates 100,000 baht to the Center for Excellence in Cancer Therapy Khun Thaveesak Vorakornvichit, Khun Anant Taveesangsiri, Khun Soras Vithitakornvijit and Khun Trisit Pisitkul, Chief of Systemic Biology University Chulalongkorn As a donor At the Faculty of Pharmacy King Chulalongkorn Memorial Hospital

Data from CU Immunotherapeutic Fund Cancer, Center for Excellence in Immunotherapy, Cancer Medical School, Chulalongkorn University Dr Trisit Pitsutkul described the research data as a hope for cancer patients.

PD-1 Protein detects Nobel laureate Tasuku Honjo Leads to the development of cancer treatment In some cancer cells, PD-1 binding proteins block lymphocytes as a "brake" stopping white blood cells from destruction of cancer.

The antibodies that have been developed here are an inhibitor of the immune control point, which prevents the process of raising the brakes, unlocking the function of white blood cells. It can destroy cancer cells. We all have natural processes that effectively detect and destroy cancer cells. Only some processes are blocked. This antibody is the hope of cancer treatment in Thailand in the future. The same applies to imported drugs and current high prices.

In patients responding to the drug. It has a very good healing effect. It works better when used in combination with other immunotherapies. Center for Excellence in Immunotherapy This medicine has been developed as an alternative to Thai people. Currently there are studies that predict antibody response. With a check of the gene. Center. Gene methods for predicting drug response have been developed. "

Interested persons can donate to: Memorial Cancer Center Chulalongkorn Savings Account Medical School Account number 408-004443-4 Siam Komercijalna banka E-mail: [email protected], Facebook fan site CU Cancer Immunotherapi Fund. The certificate can be rejected twice.

[ad_2]
Source link